* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Considerations for Analyzing Targeted NGS Data – HLA
Quantitative trait locus wikipedia , lookup
SNP genotyping wikipedia , lookup
X-inactivation wikipedia , lookup
Human genome wikipedia , lookup
Human genetic variation wikipedia , lookup
Designer baby wikipedia , lookup
Polycomb Group Proteins and Cancer wikipedia , lookup
Skewed X-inactivation wikipedia , lookup
Whole genome sequencing wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Gene expression profiling wikipedia , lookup
Minimal genome wikipedia , lookup
Genome (book) wikipedia , lookup
Genomic library wikipedia , lookup
Genomic imprinting wikipedia , lookup
Segmental Duplication on the Human Y Chromosome wikipedia , lookup
Population genetics wikipedia , lookup
Pathogenomics wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
Polymorphism (biology) wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Epigenetics of human development wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Genome evolution wikipedia , lookup
Major histocompatibility complex wikipedia , lookup
Genetic drift wikipedia , lookup
Multiple sequence alignment wikipedia , lookup
Metagenomics wikipedia , lookup
Hardy–Weinberg principle wikipedia , lookup
Microevolution wikipedia , lookup
Dominance (genetics) wikipedia , lookup
Considerations for Analyzing Targeted NGS Data HLA Tim Hague, CTO Introduction Human leukocyte antigen (HLA) is the major histocompatibility complex (MHC) in humans. Group of genes ('superregion') on chromosome 6 Essentially encodes cell-surface antigenpresenting proteins. Functions HLA genes have functions in: combating infectious diseases graft/transplant rejection autoimmunity cancer Alleles Large number of alleles (and proteins). Many alleles are already known. The number of known alleles is increasing HLA Class I Gene A B C Alleles 2013 2605 1551 Proteins 1448 1988 1119 HLA Class II Gene DRA DRB* DQA1 DQB1 DPA1 DPB1 Alleles 7 1260 47 176 34 155 Proteins 2 901 29 126 17 134 HLA Class II - DRB Alleles Gene DRB1 DRB3 DRB4 Alleles 1159 58 15 Proteins 860 46 8 DRB5 20 17 Analysis Challenges HLA genes have specific analysis challenges regardless of the sequencing technology. High Polymorphism High rate of polymorphism – up to 100 times the average human mutation rate. The HLA-DRB1 and HLA-B loci have the highest sequence variation rate within the human genome. High degree of heterozygosity – homozygotes are the exception in this region. Duplications High level of segmental duplications Lots of similar genes and lots of very similar pseudegenes. Duplicated segments can be more similar to each other within an individual than they are similar to the corresponding segments of the reference genome. Complex Genetics Particularly HLA-DRB* The DR β-chain is encoded by 4 loci, however only no more than 3 functional loci are present in a single individual, and only a maximum of 2 per chromosome. Mitigating Factors It's not all bad news: Many HLA alleles are already well known – both in terms of sequence and frequencies within the population. The HLA region is fairly small so there a high degree of linkage disequilibrium, and therefore lots of known haplotypes. Traditional Typing SSO – low resolution, high throughput, cheap SSP – very fast results, low resolution SBT – sequence-based typing, high resolution, usually done by Sanger sequencing. NGS Typing High resolution, an alternative to Sangerbased SBT Why is it needed? Sanger and HLA Sanger data is still the gold standard in the genomic sequencing industry, even though it is very expensive compared to NGS. 1 in 1'000 base error rate, if forward and reverse typing are done, error rate drops to 1 in 1'000'000. So why is it bad for HLA? Phase Resolution 2x chromosome 6 Many loci, many alleles Lots of heterozygosity Allele Phasing problem reference sequence G / T T / A consensus sequence OR??? Allele 1 Allele 2 T A Allele 1 Allele 2 A T The Problem with Sanger There is only one signal High degree of heterozygosity = high degree of ambiguity Requires statistical techniques based on known allele frequencies, plus manual intervention by trained operators Ambiguity can only be resolved statistically, which can lead to wrong assignment for rare types HLA typing by Sanger method GGACSGGRASACACGGAAWGTGAAGGCCCACTCACAGACTSACCGAGYGRACCTGGGGACCCTGCGCGGCTACTACAACCAGAGCGAGGMCGGT 550 500 450 400 350 300 250 200 150 100 50 0 Number of potential alleles NGS Advantages Can reduce ambiguity Phase resolution - two signals, but lots of short reads Cheaper and faster than Sanger Less manual intervention required NGS Data - Unphased NGS Data - Phased NGS Approaches HLA*IMP – chip based imputation engine Reference-based alignment, followed by a HLA call based on the variants detected during alignment Search against database of known alleles NGS Reference-based Fraught with difficulties Very hard to align reads to this region The variant/HLA call is only as good as the alignment No coverage = no call Has been attempted by Broad Institute (HLA Caller) and Roche Alignment Efforts RainDance provide a targeted HLA amplification kit call HLAseq. Target: the whole MHC superregion (except for some tandem repeat regions) Goal: align this data, before doing variant/HLA call. Diverse variant “density” in the MHC superregion Based on a single sample Default BWA alignment – No coverage at an exon of HLA-DMB Low coverage and orphaned reads at a HLA-DRB1 exon BWA vs more permissive alignment: higher coverage = higher noise Large targeted region without usable coverage NGS Reference-based Not providing enough coverage everywhere What about de novo? De novo assembly (MIRA) 287 contigs (longest contig: 2199 bp) Mean contig size: 268 bp Median contig size: 209 bp Total consensus: 77084 bp RainDance target: ~ 3800000 bp De novo assembly (MIRA) NGS De Novo Alignment Not enough contigs produced, not enough coverage of the target region. What about a hybrid approach? De novo assembly with “backbone” First, alignment to backbone, then de novo assembly Backbone: 2220 contigs from HG19 chr 6 (sum: 3554852 bps) → almost whole RainDance target Results: Max reads / backbone contig: 197 Max coverage: 71 De novo assembly with “backbone” NGS Typing - Alignment Based We tried: Burrows Wheeler aligner More sensitive, seed and extend aligner De novo aligner 'Hybrid' de novo aligner The variant/HLA call is only as good as the alignment The alignments were not good enough NGS Database Based Search against 'database' of known alleles Such as IMGT/HLA database, available from EBI web site Stanford, Connexio, JSI Medical, BC Cancer Agency and Omixon have all tried this approach. DB Based Approach Advantages Less mapping headaches Unambiguous results Potential to be fast Difficulties Novel allele detection Homozygous alleles Results with Exome data Exon level detail Detailed results - short read pileup Conclusions DB based approach to HLA typing is new but very promising NGS approaches can resolve much of the ambiguity of Sanger SBT DB based approach can also overcome the limitations of NGS reference-based alignment Conclusions Available DB based HLA typing tools differ in: Speed Sequencers supported Types of sequencing data supported (targeted, exome, whole genome) Ease of use Ambiguity of results Degree of manual intervention required Novel allele detection capabilities